Corteva, Inc. $CTVA Shares Purchased by Benjamin Edwards Inc.

Benjamin Edwards Inc. increased its stake in shares of Corteva, Inc. (NYSE:CTVA) by 1.7% during the 4th quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 721,749 shares of the company’s stock after acquiring an additional 12,393 shares during the quarter. Benjamin Edwards Inc.’s holdings in Corteva were worth $48,378,000 at the end of the most recent quarter.

Several other hedge funds and other institutional investors have also recently bought and sold shares of CTVA. Perpetual Ltd raised its stake in Corteva by 78,688.5% during the 4th quarter. Perpetual Ltd now owns 2,615,779 shares of the company’s stock worth $175,336,000 after acquiring an additional 2,612,459 shares in the last quarter. Amundi raised its stake in Corteva by 125.3% during the 3rd quarter. Amundi now owns 3,415,554 shares of the company’s stock worth $219,620,000 after acquiring an additional 1,899,248 shares in the last quarter. Squarepoint Ops LLC raised its stake in Corteva by 423.6% during the 3rd quarter. Squarepoint Ops LLC now owns 1,738,139 shares of the company’s stock worth $117,550,000 after acquiring an additional 1,406,199 shares in the last quarter. Man Group plc raised its stake in Corteva by 16,474.3% during the 3rd quarter. Man Group plc now owns 1,294,125 shares of the company’s stock worth $87,522,000 after acquiring an additional 1,286,317 shares in the last quarter. Finally, State Street Corp increased its stake in Corteva by 3.6% in the third quarter. State Street Corp now owns 35,280,805 shares of the company’s stock valued at $2,386,041,000 after purchasing an additional 1,230,074 shares during the period. 81.54% of the stock is currently owned by institutional investors and hedge funds.

Insider Buying and Selling

In related news, insider Brian Titus sold 8,311 shares of the business’s stock in a transaction dated Friday, February 20th. The shares were sold at an average price of $76.55, for a total transaction of $636,207.05. Following the sale, the insider owned 8,090 shares of the company’s stock, valued at approximately $619,289.50. The trade was a 50.67% decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at this link. Corporate insiders own 0.15% of the company’s stock.

Analysts Set New Price Targets

CTVA has been the topic of a number of recent research reports. Citigroup lifted their price objective on shares of Corteva from $74.00 to $80.00 and gave the company a “neutral” rating in a research note on Thursday, February 5th. Berenberg Bank lifted their price objective on shares of Corteva from $68.00 to $78.00 and gave the company a “hold” rating in a research note on Thursday, March 26th. The Goldman Sachs Group lifted their price objective on shares of Corteva from $88.00 to $96.00 and gave the company a “buy” rating in a research note on Tuesday, April 14th. Weiss Ratings restated a “hold (c)” rating on shares of Corteva in a research note on Wednesday, April 22nd. Finally, CICC Research lifted their price objective on shares of Corteva from $70.00 to $80.00 and gave the company an “outperform” rating in a research note on Wednesday, February 11th. Fourteen analysts have rated the stock with a Buy rating and nine have given a Hold rating to the company’s stock. Based on data from MarketBeat.com, the stock has a consensus rating of “Moderate Buy” and a consensus target price of $86.38.

Corteva Stock Down 0.1%

CTVA stock opened at $80.97 on Friday. The company has a market cap of $54.36 billion, a P/E ratio of 51.24, a P/E/G ratio of 2.77 and a beta of 0.59. Corteva, Inc. has a 52 week low of $60.53 and a 52 week high of $85.63. The company’s 50-day moving average price is $80.39 and its 200 day moving average price is $72.12. The company has a current ratio of 1.43, a quick ratio of 0.96 and a debt-to-equity ratio of 0.07.

Corteva (NYSE:CTVA) last released its quarterly earnings data on Tuesday, February 3rd. The company reported $0.22 EPS for the quarter, hitting analysts’ consensus estimates of $0.22. The firm had revenue of $3.91 billion for the quarter, compared to the consensus estimate of $4.23 billion. Corteva had a net margin of 6.29% and a return on equity of 9.06%. The firm’s revenue was down 1.7% on a year-over-year basis. During the same quarter in the previous year, the firm earned $0.32 earnings per share. Corteva has set its FY 2026 guidance at 3.450-3.700 EPS. On average, research analysts expect that Corteva, Inc. will post 3.62 earnings per share for the current fiscal year.

Corteva Announces Dividend

The business also recently disclosed a quarterly dividend, which will be paid on Monday, June 15th. Investors of record on Monday, June 1st will be issued a dividend of $0.18 per share. The ex-dividend date of this dividend is Monday, June 1st. This represents a $0.72 dividend on an annualized basis and a yield of 0.9%. Corteva’s payout ratio is currently 45.57%.

Corteva Profile

Corteva, Inc (NYSE: CTVA) is an independent global agriculture company that was established as a publicly traded firm in mid?2019 following the separation of the agriculture businesses from DowDuPont. The company focuses on delivering technologies and products that help farmers increase productivity and manage crop health. Corteva’s operations combine seed genetics, crop protection chemistries, digital tools and biological solutions to address the full cycle of crop production.

Core business activities include research and development of seed genetics and trait technologies, formulation and sale of crop protection products (such as herbicides, insecticides and fungicides), and the development of seed treatments and biologicals.